Augmented reality and pain during botulinum neurotoxin A injections in children with cerebral palsy: A randomized controlled trial
Developmental Medicine & Child Neurology · 2026
DOI: 10.1111/dmcn.70143 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Developmental Medicine & Child Neurology, 2026. Verfasst von Emmanuelle Chaléat-Valayer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Massues Rehabilitation Center - French Red Cross, Lyon, France. Hauptthemen laut MEDLINE: Cerebral Palsy, Botulinum Toxins, Type A, Neuromuscular Agents, Pain Management. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Fondation APICIL, Fondation Motrice.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
To assess the effect of the augmented reality application called Minidocs on pain reduction during botulinum neurotoxin A (BoNT‐A) injections in children with cerebral palsy (CP).
Method
Children with CP aged 3 to 8 years undergoing BoNT‐A injection were randomized to usual pain management alone ( n = 41) or combined with Minidocs ( n = 39). Minidocs is an augmented reality application on a digital device offering several games including active distraction, hypnotic suggestion, and counter‐aggression features. The primary outcome was the child's pain during BoNT‐A injection, combining patient‐reported (Faces Pain Scale [FPS]) and observer‐reported (Face, Legs, Activity, Cry, Consolability scale [FLACC]) outcomes. Secondary outcomes included anxiety of children (Modified Yale Preoperative Anxiety Scale) and parents (State–Trait Anxiety Inventory Form Y‐1), and satisfaction with Minidocs.
Results
In total, 14 out of 41 (34.1%) children in the control group and 7 out of 39 (17.9%) children in the experimental group experienced pain (i.e. FPS or FLACC scores ≥4). The difference between groups was not statistically significant (odds ratio 0.36; 95% confidence interval 0.11–1.16; p = 0.087). Changes in anxiety scores from before to after injection did not differ between groups. Satisfaction with the use of Minidocs was high.
Interpretation
This study did not demonstrate the benefit of augmented reality on pain reduction. The counter‐aggression feature is an innovation of Minidocs worth exploring. Further studies are needed to identify profiles of children who respond to non‐drug therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Massues Rehabilitation Center - French Red Cross, Lyon, France.
- Bois Larris Rehabilitation Center for Children - French Red Cross, Lamorlaye, France.
- Hospices Civils de Lyon, Public Health Department, Biostatistics and Bioinformatics Unit, Lyon, France.
- Hospices Civils de Lyon, Public Health Department, Clinical Research and Epidemiology Unit, Lyon, France.
- CHU de Saint-Etienne, Neurology Unit, Saint-Etienne, France.
- INSERM U 1219, ACTIVE Team, Bordeaux Population Health, Bordeaux University, Bordeaux, France.
ORCID-Profile: Rachel Bard-Pondarré, Olivia Febvey-Combes
Förderung
- Fondation APICIL
- Fondation Motrice
Zitieren
APA
Chaléat-Valayer, E., Lucet, A., Denis, A., Touzet, S., Rouch, I., Bard-Pondarré, R., Zelmar, A., & Febvey-Combes, O. (2026). Augmented reality and pain during botulinum neurotoxin A injections in children with cerebral palsy: A randomized controlled trial. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.70143
Vancouver
Chaléat-Valayer E, Lucet A, Denis A, Touzet S, Rouch I, Bard-Pondarré R, et al. Augmented reality and pain during botulinum neurotoxin A injections in children with cerebral palsy: A randomized controlled trial. Developmental Medicine & Child Neurology. 2026. doi:10.1111/dmcn.70143
BibTeX
@article{ChalatValayer2026,
author = {Chaléat-Valayer, Emmanuelle and Lucet, Aurélie and Denis, Angélique and Touzet, Sandrine and Rouch, Isabelle and Bard-Pondarré, Rachel and Zelmar, Amélie and Febvey-Combes, Olivia},
title = {Augmented reality and pain during botulinum neurotoxin A injections in children with cerebral palsy: A randomized controlled trial},
journal = {Developmental Medicine & Child Neurology},
year = {2026},
doi = {10.1111/dmcn.70143}
}
EUVIMED